Circulating FGF23 is not associated with cardiac dysfunction, atherosclerosis, infection or inflammation in hemodialysis patients.
Takashi Y, Wakino S, Minakuchi H, Ishizu M, Kuroda A, Shima H, Tashiro M, Miya K, Okada K, Minakuchi J, Kawashima S, Matsuhisa M, Matsumoto T, Fukumoto S.
Takashi Y, et al. Among authors: matsumoto t.
J Bone Miner Metab. 2020 Jan;38(1):70-77. doi: 10.1007/s00774-019-01027-7. Epub 2019 Aug 16.
J Bone Miner Metab. 2020.
PMID: 31420749